ROP Risk Management 2021 : Current Opinion in Ophthalmology

Secondary Logo

Journal Logo

RETINOPATHY OF PREMATURITY: NICU TO ADULTHOOD: Edited by Audina Berrocal and Antonio Capone Jr.

ROP Risk Management 2021

Gold, Robert S.

Author Information
Current Opinion in Ophthalmology 32(5):p 494-497, September 2021. | DOI: 10.1097/ICU.0000000000000790


Purpose of review 

It is important for ophthalmologists to keep current with up-to-date recommendations for screening, treating, and follow-up of infants with retinopathy of prematurity (ROP). This paper will review updated ROP Safety Net protocols and Policy Statements to stress that following risk management principles can avoid claims that could arise from poor visual outcomes.

Recent findings 

Ophthalmic Mutual Insurance Company (OMIC) has been proactive in ROP risk management with development of the ROP Safety Net in 2006. The most recent updates in 2018 and 2019 address OMIC's claims experience and the factors leading to these claims. Clinical, systems, physician, and parent factors will be clarified. In addition, when to stop ROP screening has evolved and will be delineated and discussed to further aid in the process of care of these high-risk infants.


Ophthalmologists that screen and treat infants with ROP must keep updated with safety net protocols and institute them in their Neonatal Intensive Care Units (NICU) and offices as they take care of these babies to minimize legal risks from a claim. In addition, keeping up with policy statements is essential to successfully following these infants in the most appropriate fashion.

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid